Literature DB >> 27770713

Facial emotion recognition and alexithymia in Chinese male patients with deficit schizophrenia.

Xiao Wei Tang1, Miao Yu2, Wei Wei Duan3, Xiang Rong Zhang4, Wei Wei Sha1, Xiang Wang5, Xiao Bin Zhang6.   

Abstract

Deficit schizophrenia (DS) has been proposed as a pathophysiologically distinct schizophrenia subtype. This study investigated facial emotion recognition deficits and alexithymia in DS and non-deficit schizophrenia patients (NDS) and their relationships with other clinical variables. The Brief Psychiatric Rating Scale (BPRS), Scale for the Assessment of Negative Symptoms (SANS), and Scale for the Assessment of Positive Symptoms (SAPS) were employed to evaluate the psychiatric symptoms in patients with schizophrenia. Facial emotion recognition deficits and Alexithymia were assessed in DS, NDS, and control groups by The Chinese Facial Emotion Test (CFET) and the Toronto Alexithymia Scale-20 (TAS-20). Compared with control group, both DS and NDS patients exhibited more severe facial emotion recognition impairments, with the exception of "happy faces" in NDS patients, as well as higher alexithymia scores. In DS patients, correct frequency for fear recognition and total CFET score were negatively correlated with TAS-20 Factor 3 subscore for "externally oriented thinking". Total TAS-20 score was positively correlated with BPRS negative symptom and SANS score in DS patients. In contrast, there were no correlations between TAS-20 scores/subscores and psychiatric symptoms in NDS patients. These findings indicated distinct facial emotion recognition impairments in DS and NDS patients. Alexithymia might be specifically related to the negative symptom in DS patients, suggesting DS as a unique schizophrenic subtype.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27770713     DOI: 10.1016/j.psychres.2016.09.055

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  The percentage and clinical correlates of alexithymia in stable patients with schizophrenia.

Authors:  Yun Yi; Yuanyuan Huang; Rui Jiang; Qiang Chen; Mingzhe Yang; Hehua Li; Yangdong Feng; Shixuan Feng; Sumiao Zhou; Lixin Zhang; Yuping Ning; Zezhi Li; Fengchun Wu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-10-14       Impact factor: 5.760

2.  Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels.

Authors:  Yaqin Zhao; Wenhuan Xiao; Kuanyu Chen; Qiongqiong Zhan; Fei Ye; Xiaowei Tang; Xiaobin Zhang
Journal:  BMC Psychiatry       Date:  2019-12-16       Impact factor: 3.630

3.  A bottom-up model of functional outcome in schizophrenia.

Authors:  Hongge Luo; Yanli Zhao; Fengmei Fan; Hongzhen Fan; Yunhui Wang; Wei Qu; Zhiren Wang; Yunlong Tan; Xiujun Zhang; Shuping Tan
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

4.  Exploring the link between cognitive deficit, self-esteem, alexithymia, and depressive symptom of schizophrenia.

Authors:  Chen He; Xueying Zhang; Qingrong Xia; Hua Gao; Junwei Yan; Xuequan Chen; Hui Yuan; Yang Zhang; Wen Xie; Cuizhen Zhu
Journal:  Brain Behav       Date:  2022-06-08       Impact factor: 3.405

5.  Prevalence and associated factors of alexithymia among adult prisoners in China: a cross-sectional study.

Authors:  Li Chen; Linna Xu; Weimin You; Xiaoyan Zhang; Nanpeng Ling
Journal:  BMC Psychiatry       Date:  2017-08-03       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.